Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Objectives: To develop a locally deployed DeepSeek-powered closed-loop system for electronic nursing documentation quality control (QC) and evaluate its clinical efficacy through a multidimensional validation framework.
Materials And Methods: We implemented a three-dimensional (3D) QC framework (real-time, final, and vertical QC). A retrospective analysis of 556 electronic nursing records was conducted to evaluate pre- and postimplementation outcomes, with documentation accuracy and audit efficiency assessed via blinded nurse evaluations.
Results: After implementation, omission rates decreased from 7.19% to 1.79%, the prevalence of logical inconsistencies decreased from 9.35% to 0.72%, and the prevalence of timeliness errors decreased from 8.63% to 0%. The QC time per record decreased by 3.2-fold. Nurse satisfaction was evaluated using the Clinical Nursing Information System Effectiveness Evaluation Scale (Zhao Y, Gu Y, Zhang X, et al. Developed the clinical nursing information system effectiveness evaluation scale based on the new D&M model and conducted reliability and validity evaluation. Chin J Prae Nurs. 2020;36:544-550. https://doi.org/10.3760/cma.j.issn.1672-7088.2020.07.013), yielding a total score of 102.73 ± 3.25 out of a maximum 115 points.
Discussion: This study demonstrates that the Artificial Intelligence (AI)-powered closed-loop QC system significantly enhances documentation accuracy and workflow efficiency while ensuring data security. The 3D framework (real-time, final, and vertical QC) represents a paradigm shift from reactive to proactive quality governance in nursing practice. High nurse satisfaction (102.73/115) confirms clinical viability, offering a scalable model for intelligent health-care quality ecosystems. Future work should explore federated learning for multicenter deployment and regulatory frameworks for clinical AI.
Conclusion: DeepSeek demonstrated robust efficacy in enhancing QC accuracy and workflow efficiency, with localized deployment ensuring data security. This system redefines nursing documentation management, heralding an era of "intelligent negative feedback" in health-care quality ecosystems.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1093/jamia/ocaf109 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
The PROtective VEntilation (PROVE) Network - advancing research and collaboration in mechanical ventilation.
Crit Care Sci
September 2025
Universitätsklinikum Carl Gustav Carus - Dresden, Sachsen, Germany.
The PROtective VEntilation (PROVE) Network is a globally-recognized collaborative research group dedicated to advancing research, education, and collaboration in the field of mechanical ventilation. Established to address critical questions in intraoperative and intensive care ventilation, the network focuses on improving outcomes for patients undergoing mechanical ventilation in diverse settings, including operating rooms, intensive care units, burn units, and resource-limited environments in low- and middle-income countries. The PROVE Network is committed to generating high-quality evidence through a comprehensive portfolio of investigations, including randomized clinical trials, observational research, and meta-analyses.
View Article and Find Full Text PDFOn-Demand Nanoliter Delivering Platform via Electrical-Activated Microdroplet Assembling.
Nano Lett
September 2025
Pillar of Engineering Product Development, Singapore University of Technology and Design, 8 Somapah Road, Singapore 487372, Singapore.
Precise delivery of nanoliter-scale reagents is essential for high-throughput biochemical assays, yet existing platforms often lack real-time control and selective content fusion. Conventional methods rely on passive encapsulation or stochastic pairing, limiting both throughput and biochemical specificity. Here, we introduce an on-demand nanoliter delivery platform that seamlessly integrates electrical sensing, triggered droplet merging, and passive sorting in a single continuous flow.
View Article and Find Full Text PDFArtificial Intelligence for Management of Major Depression: Initial Design, Progress, and Research Plans.
Alpha Psychiatry
August 2025
Information Sciences and Technology, George Mason University, Fairfax, VA 22030, USA.
Background: Herein, we report on the initial development, progress, and future plans for an autonomous artificial intelligence (AI) system designed to manage major depressive disorder (MDD). The system is a web-based, patient-facing conversational AI that collects medical history, provides presumed diagnosis, recommends treatment, and coordinates care for patients with MDD.
Methods: The system includes seven components, five of which are complete and two are in development.
Updates on Parkinson's Disease.
Neuropsychiatr Dis Treat
September 2025
Department of Radiology, No. 926 Hospital, Joint Logistics Support Force of PLA, Kaiyuan, Yunnan, 661699, People's Republic of China.
Parkinson's disease (PD) represents a progressive neurodegenerative disorder with escalating global burden, with mechanistic studies revealing α-synuclein propagation through gut-brain axis, mitochondrial defects, and neuroinflammatory cascades driven by genetic-environmental interplay. Recent advancements in diagnostic paradigms have successfully combined α-synuclein seed amplification assays with multimodal neuroimaging techniques, achieving an impressive diagnostic accuracy of 92% during the prodromal stages of disease. Phase II trials highlight disease-modifying potential of α-synuclein-targeting immunotherapies (40% reduction in motor decline) and LRRK2 kinase inhibitors showing blood-brain barrier penetration.
View Article and Find Full Text PDF[Advanced Hybrid Closed Loop (AHCL) System for Glucose Monitoring and Automatic Insulin Microinfusion in Dialysis].
G Ital Nefrol
August 2025
Infermiere Professionale SSD Nefrologia e Dialisi P.O. Soverato, ASP CZ.
Management of diabetes mellitus in hemodialysis is highly complex due to increased glycemic variability and hypoglycemic risk. The use of technologies applied to diabetes has been shown to improve glycemic control, however data in dialysis patients are limited. To describe the efficacy and safety of the minimed 780G AHCL system in a stable hemodialysis patient and during hospitalization in the Intensive Care Unit (ICU).
View Article and Find Full Text PDF